Streamlining Radiation Oncology GLP-1 Prior Auth Workflows

Managing prior authorizations for GLP-1 medications within a busy radiation oncology practice introduces unique administrative challenges. Klivira's platform automates radiation oncology GLP-1 prior auth, ensuring efficiency without compromising patient care.

Revenue cycle directors and prior authorization coordinators in radiation oncology face a dual challenge: managing complex PAs for advanced therapies like IMRT and proton beam therapy, alongside a growing volume of drug PAs, including GLP-1 receptor agonists. This creates significant administrative overhead, diverting resources from critical oncology-specific tasks and potentially delaying access to essential medications for patients.

The Unique Prior Auth Burden in Radiation Oncology

Radiation oncology practices commonly manage prior authorizations for high-cost, high-complexity procedures such as IMRT, proton beam therapy, SBRT, and brachytherapy. The emergence of GLP-1 receptor agonists like Ozempic, Wegovy, Mounjaro, Zepbound, and Saxenda, often prescribed for co-morbid conditions such as Type 2 Diabetes or obesity, adds a distinct layer of high-volume drug prior authorizations. These drug PAs, while different in nature from procedure PAs, demand meticulous documentation and frequent follow-up, straining already-lean administrative teams.

Klivira's Targeted Automation for GLP-1 PAs

Klivira's platform is engineered to integrate seamlessly into existing radiation oncology workflows, automating the specific complexities of GLP-1 prior authorizations. By leveraging EMR data, Klivira reduces the manual effort required for these high-volume drug PAs, allowing staff to prioritize the intricate authorization processes for radiation treatments. Our system handles the nuances of indication classification and payer-specific requirements, a critical need identified by sources like the CAQH Index regarding pharmacy ePA volumes.

Key Steps in Klivira's GLP-1 Prior Auth Workflow

**Indication Classification:** Klivira identifies Type 2 Diabetes versus obesity indications directly from EMR diagnosis and clinical context, crucial for drugs like Ozempic or Mounjaro.
**Per-Payer Obesity Coverage Routing:** Our policy engine maintains up-to-date per-payer obesity benefit statuses (covered, restricted, not-covered) and routes requests accordingly, optimizing submission success.
**Step Therapy Documentation Automation:** The system automatically pulls metformin trial history, BMI documentation, and comorbidity status from FHIR-enabled EMRs, fulfilling common step-therapy gates.
**Brand-Specific PA Criteria:** Klivira applies brand-specific logic for different GLP-1 products (e.g., Wegovy vs. Zepbound), ensuring accurate and compliant submissions based on the latest payer rules.
**Integrated Specialty Pharmacy Fulfillment:** Post-approval, the platform facilitates routing to specialty pharmacies, a common requirement for many GLP-1 products.

Seamless EMR Integration and Data Exchange

Klivira integrates with leading EMR systems commonly used in radiation oncology, allowing for the automated extraction of clinical data essential for GLP-1 PAs. This includes patient demographics, diagnoses, lab results (e.g., A1C), and medication history. The ability to pull this data through standards like FHIR minimizes manual data entry and reduces the risk of errors, ensuring that all necessary information, from ADA Standards of Care criteria for T2D to BMI for obesity, is included in the X12 278 or ePA submission.

Empowering Radiation Oncology Staff

By automating the repetitive and rules-based aspects of GLP-1 prior authorizations, Klivira empowers radiation oncology PA coordinators and revenue cycle teams. This frees up valuable time for staff to focus on the complex, judgment-intensive prior authorizations for radiation therapy procedures (IMRT, SBRT), patient-financial counseling, and addressing any payer denials. Our solution ensures that patients prescribed GLP-1 medications alongside their cancer treatment experience fewer delays in accessing their prescribed therapies.

Frequently asked questions

How does Klivira handle GLP-1 PAs for patients undergoing radiation therapy?

Klivira integrates with your EMR to identify patients prescribed GLP-1s alongside their radiation oncology treatments. Our system then automates the PA process by extracting relevant clinical data, applying payer-specific rules for indication and step therapy, and submitting the request, minimizing administrative burden on your staff.

What EMR data points are critical for GLP-1 PAs in an oncology setting?

For GLP-1 PAs, critical EMR data points include diagnosis codes (e.g., Type 2 Diabetes, obesity), lab results (e.g., A1C), BMI, medication history (especially for step therapy requirements like metformin), and comorbidity status. Klivira's system is designed to automatically pull these specific data elements from your EMR.

Does Klivira address step therapy requirements for GLP-1s like Ozempic or Wegovy?

Yes, Klivira's platform automates the documentation of step therapy requirements for GLP-1s. It pulls relevant information, such as prior trials of preferred medications (e.g., metformin for Type 2 Diabetes), directly from the EMR, ensuring that these common payer requirements are met during the PA submission.

How does Klivira manage varying payer policies for obesity indications for GLP-1s?

Klivira's policy engine maintains an up-to-date database of per-payer obesity benefit statuses. When a GLP-1 is indicated for obesity, the system automatically routes the request according to whether the specific payer covers, restricts, or excludes anti-obesity medications, optimizing the submission strategy.

Can Klivira help with GLP-1 PAs even if the patient's primary care is outside our radiation oncology clinic?

Klivira's automation relies on the data available in your integrated EMR. If the prescribing information and necessary clinical context for the GLP-1 are documented within your EMR system, Klivira can process the PA. For external prescriptions, ensuring comprehensive EMR documentation is key for automation.